Shanghai MicroPort MedBot (Group) Co., Ltd. (02252.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 3Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1

ValuationView details →

P/E (Fwd)

157.4x

EV/EBITDA

−37.2x

Market Cap

HKD 21.71B

MomentumView details →

1D Return

+0.00%

YTD Return

−12.92%

RSI (14)

39.9

ValuationView details →

P/E (Fwd)

157.4x

EV/EBITDA

−37.2x

Market Cap

HKD 21.71B

RSI (14)

39.9

MomentumView details →

1D Return

+0.00%

YTD Return

−12.92%

ProfitabilityView details →

Gross Margin

43.65%

Net Margin

−110.36%

EBITDA Margin

−61.11%

ROE (TTM)

−217.13%

ROA (TTM)

−66.81%

Asset Turnover

0.57x

GrowthView details →

Revenue YoY

+540.53%

EPS YoY

+60.18%

FCF YoY

+78.28%

Revenue CAGR 3Y

+194.37%

EPS CAGR 3Y

+63.64%

EBITDA YoY

+73.93%

EarningsView details →

EPS (Actual)

HKD 0.03

EPS Surprise

0.00%

Beats (12Q)

0/12

Next Q EPS Est

HKD 0.00

Avg Surprise (4Q)

0.00%

Rev Surprise

−0.09%

Capital & dividendView details →

Debt/Equity

1.04x

Current Ratio

2.30x

Quick Ratio

2.01x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

808.32M

Net Income (TTM)

−892.07M

Op. CF (TTM)

−329.08M

Next earningsMar 31, 2027 →

Latest newsMore news →

Hang Seng Biotech ETF (E Fund) announced that due to the suspension of constituent stocks MicroPort Scientific and MicroPort MedBot from September 1, 2026, it will adjust the clearing and settlement arrangements for subscription and redemption cash substitutions for these two securities starting September 2, 2026.3d ago

Shanghai MicroPort MedBot's Toumai Remote surgical robot received CE mark approval from the European Union, granting market access.73d ago

Similar companies

STERIS plcSTE Guangdong True Health Medical Technology Development Co., Ltd.02697.HK Zimmer Biomet Holdings, Inc.ZBH Koninklijke Philips N.V.PHG DexCom, Inc.DXCM 惠泰医疗688617.SH Find similar companies →

Latest newsMore news →

Hang Seng Biotech ETF (E Fund) announced that due to the suspension of constituent stocks MicroPort Scientific and MicroPort MedBot from September 1, 2026, it will adjust the clearing and settlement arrangements for subscription and redemption cash substitutions for these two securities starting September 2, 2026.3d ago Shanghai MicroPort MedBot's Toumai Remote surgical robot received CE mark approval from the European Union, granting market access.73d ago